LivaNova
Provides meaningful solutions for the benefit of patients, healthcare professionals and healthcare systems.
Launch date
Employees
Market cap
€2.4b
Enterprise valuation
€2.7b (Public information from Sep 2024)
Share price
$51.23 LIVN
Company register number 09451374
London England (HQ)
Financials
Estimates*
| USD | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Revenues | 934m | 1.0b | 1.0b | 1.2b | 1.2b | 1.3b | 1.4b |
| % growth | (14 %) | 11 % | (1 %) | 13 % | 7 % | 5 % | 6 % |
| EBITDA | 38.5m | 67.0m | 111m | 103m | 273m | 313m | 328m |
| % EBITDA margin | 4 % | 6 % | 11 % | 9 % | 22 % | 24 % | 24 % |
| Profit | (345m) | (136m) | (86.2m) | 17.5m | 17.6m | 97.8m | 127m |
| % profit margin | (37 %) | (13 %) | (8 %) | 2 % | 1 % | 8 % | 9 % |
| EV / revenue | 3.9x | 4.5x | 2.9x | 2.4x | 2.1x | 1.9x | 1.7x |
| EV / EBITDA | 94.0x | 69.9x | 26.9x | 27.0x | 9.7x | 8.0x | 7.2x |
| R&D budget | 153m | 183m | 156m | 194m | - | - | - |
| R&D % of revenue | 16 % | 18 % | 15 % | 17 % | - | - | - |
Source: Dealroom estimates
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | N/A | IPO | |
* | N/A | $300m | Post IPO Debt |
| Total Funding | - | ||
Related Content
Recent News about LivaNova
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.
ACQUISITION by LivaNova Dec 2017
ACQUISITION by LivaNova Oct 2015
ACQUISITION by LivaNova May 2022
ACQUISITION by LivaNova Feb 2018
ACQUISITION by LivaNova May 2017
